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Clostridium difficile flagella induce 
a pro-inflammatory response in 
intestinal epithelium of mice in 
cooperation with toxins
Jameel Batah1, Hussein Kobeissy1, Phuong Trang Bui Pham1, Cécile Denève-Larrazet1, Sarah 
Kuehne2, Anne Collignon1, Claire Janoir-Jouveshomme1, Jean-Christophe Marvaud1 &  
Imad Kansau1
Clostridium difficile is the most important enteropathogen involved in gut nosocomial post-antibiotic 
infections. The emergence of hypervirulent strains has contributed to increased mortality and morbidity 
of CDI. The C. difficile toxins contribute directly to CDI-associated lesions of the gut, but other bacterial 
factors are needed for the bacteria to adhere and colonize the intestinal epithelium. The C. difficile 
flagella, which confer motility and chemotaxis for successful intestinal colonization, could play an 
additional role in bacterial pathogenesis by contributing to the inflammatory response of the host and 
mucosal injury. Indeed, by activating the TLR5, flagella can elicit activation of the MAPK and NF-κB 
cascades of cell signaling, leading to the secretion of pro-inflammatory cytokines. In the current study, 
we demonstrate, by using an animal model of CDI, a synergic effect of flagella and toxins in eliciting 
an inflammatory mucosal response. In this model, the absence of flagella dramatically decreases 
the degree of mucosal inflammation in mice and the sole presence of toxins without flagella was not 
enough to elicit epithelial lesions. These results highlight the important role of C. difficile flagella in 
eliciting mucosal lesions as long as the toxins exert their action on the epithelium.
The Gram-positive anaerobic bacterium Clostridium difficile is responsible for intestinal nosocomial 
post-antibiotic infections in developed countries. The clinical features of C. difficile infection (CDI) include diar-
rhea, moderately serious disease, and severe pseudomembranous colitis. The major risk factors associated with 
CDI are antibiotic exposure, hospitalization, and advanced aged1. A dramatic increase of severe disease and mor-
tality of CDI have been observed in North America, Europe and Australia2, 3, mainly resulting from the emer-
gence of highly virulent and epidemic C. difficile strains3, 4.
The C. difficile toxins TcdA and TcdB are largely involved in lesions of the gut observed during CDI5, 6, but 
other factors such as adhesins7–10, hydrolytic enzymes11, 12, the S-layer proteins13, and cell wall proteins9, are 
needed for the bacteria to adhere and colonize the gut. The C. difficile flagella confer motility and chemotaxis for 
successful intestinal colonization following disruption of the bacterial microbiota14, 15. However, flagella could 
play an additional role in bacterial pathogenesis by contributing to the inflammatory response of the host and 
mucosal injury. Indeed, flagellin, the principal component of bacterial flagella, is recognized by the Toll-like 
receptor 5 (TLR5)16, one of the Pattern Recognition Receptor (PRR) involved in innate immune response, which 
is mostly localized at the basolateral pole of intestinal cells. The TLR5-flagellin interaction triggers activation of 
the MAPK and NF-κB cascades of cell signaling, leading to the secretion of pro-inflammatory cytokines17, 18.
To date, few studies have addressed this role for C. difficile flagella. Yoshino et al. showed that C. difficile flagel-
lin induces activation of NF-κB and the p38 MAPK, thus promoting the synthesis of IL-8 and CCL20 in intesti-
nal epithelial cells19. These authors showed that a pretreatment with toxin TcdB enhances the flagellin-induced 
cytokine production by cells. Recently, we reported that the interaction of C. difficile flagellin and TLR5 
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predominantly activates the NF-κB pathway, thus leading to up-regulation of pro-inflammatory gene expression 
and subsequent synthesis of pro-inflammatory mediators20.
The aim of the current study was to evaluate the role of C. difficile flagella in cooperation with toxins in elicit-
ing an inflammatory host response during in vivo infection. By using a conventional mouse model of CDI and dif-
ferent C. difficile mutants lacking flagella or toxins, we observed that the absence of flagella dramatically decreases 
the degree of mucosal inflammation in mice and the sole presence of toxins without flagella was not enough to 
elicit epithelial lesions as observed in mice infected with wild-type bacteria. These results highlight the important 
role of C. difficile flagella in eliciting mucosal lesions as long as the toxins exert their action on the epithelium.
Results
Toxigenic and flagellated C. difficile R20291 strain, in contrast to non-flagellated or non-toxi-
genic strains, induce a caecal inflammatory response in the CDI mouse model. To study the role 
of C. difficile flagella in the intestinal inflammatory response in vivo, we used a CDI model in conventional mice21. 
As expected, all mice infected with the hypervirulent WT R20291 strain (n = 10) developed CDI with diarrhea on 
the first day post-infection and showed ruffled fur and reduced activity at day 2 after challenge, with a 50% (6/12) 
mortality rate from day 2 post-challenge. A strong colitis with significant caecal dilatation, luminal liquid accu-
mulation and wall hyperemia was observed in all WT-infected mice. To measure the degree of inflammation of 
the caecal mucosa of mice, a histological score based on 4 criteria (submucosa edema, inflammatory cell infiltrate, 
epithelial injury and loss of goblet cells) was developed (Supplementary Table S1). Indeed, a high inflammation 
score of 12 out of 15 was observed in caecal sections of WT R20291-infected mice compared to uninfected mice 
(Fig. 1A,B).
In contrast, mice infected with the fliC (unflagellated but toxigenic) mutant (n = 10) presented only soft 
stools at day 1 or 2 post-infection, and survived the challenge. Similarly, the animals infected with flagellated 
but non-toxigenic A−B− mutant (n = 10) did not develop CDI and all animals survived at day 2 post-infection. 
A mild colitis without caecal dilatation or wall hyperemia was observed in the fliC or A−B− mutant-infected 
mice, compared to the group of non-infected mice (n = 10), suggesting that both TcdA/TcdB toxins and fla-
gella are necessary to induce CDI in this mice model. Moreover, a slight inflammation with moderate edema, 
focal erosion, mild luminal cell desquamation and minimal loss of goblet cells was observed in the fliC or 
A−B− mutant-infected mice (Fig. 1C,D). A statistically significant difference (P < 0.01) was observed between 
Figure 1. C. difficile R20291 flagella are involved in caecal inflammation of mice. C57BL/6 mice (n = 10) 
were infected or not and caeca were collected at the clinical end point day 2 for histology. (A) Representative 
histology of caecum of healthy uninfected mice (control) with epithelium integrity; (B) R20291 WT-infected 
mice with ulcerative colitis, necrosis, desquamation, exudates and necrotic cells in the intestinal lumen, edema, 
inflammatory submucosal cell infiltration, loss of architecture of epithelium and presence of pseudomembranes 
in caecum; (C) R20291 fliC and (D) A−B− mutant-infected mice with edema, focal desquamation of necrotic 
cells in the intestinal lumen and submucosal cell infiltrate; (E) R20291 motB mutant-infected mice with similar 
degree of mucosal lesion than R20291 WT-infected mice (200X magnification). Bar = 200 µm. (F) Inflammation 
histological scores for individual mice in each group. The horizontal lines represent the mean scores for each 
group of animals. (G) Individual evaluation criteria of intestinal inflammation. The bars represent the mean 
scores for each group of animals and standard deviations. *P < 0.01 compared to WT-infected mice.
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the score of the WT-infected mice group (score 12) compared to that of the other two groups (fliC and A−B− 
mutant-infected mice, scores 8 and 6 respectively) and control (score 0, Fig. 1F). The analysis of each inflamma-
tion criteria separately also showed (except for edema) a statistically significant difference (P < 0.01) between the 
WT-infected mice and the other two groups (Fig. 1G).
Toxigenic and flagellum-paralyzed C. difficile R20291 mutant induces a caecal inflammatory 
response in mice. In order to test the role of flagellum in the epithelial inflammatory response we also 
performed in vivo experiments using a motB mutant in R20291 strain which is toxigenic and flagellated but not 
mobile. The motB gene is involved in synthesis of the flagellar motor. Interestingly, all mice infected with the para-
lyzed flagella motB mutant (n = 10) developed CDI with a high (50%) mortality rate, a strong colitis with signifi-
cant caecal dilatation, luminal liquid accumulation and wall hyperemia as observed in the WT R20291-infected 
mice. Indeed, as for WT R20291-infected mice, mice infected with the flagella paralyzed motB mutant showed 
the highest inflammation score (12 out of 15) in caecal sections compared to uninfected mice (Fig. 1E), with a 
statistically significant difference (P < 0.01) between the score of the motB mutant-infected mice group (score 12) 
and those of the other two groups (fliC and A−B− mutant-infected mice, scores 8 and 6 respectively) and control 
(score 0, Fig. 1F). The individual inflammation criteria were similar to those of the WT-infected mice and a sta-
tistically significant difference (P < 0.01) between the motB-infected mice and the other two groups was observed 
(Fig. 1G).
To note, in all performed experiments, the differences observed between the different groups of animals were 
not due to differences in the rate of fecal colonization since the fecal shedding of vegetative forms and spores 
reached by these strains were similar for the 4 groups of mice at days 1 and 2 post-infection (Supplementary 
Fig. S1A,B). Moreover, as expected, the feces from WT strain, fliC and motB mutant-infected mice, but not 
those from A−B− mutant-infected mice, showed a strong and similar level of cytotoxic activity (Supplementary 
Fig. S2A), thus indicating that in vivo toxin production of the WT R20291 strain and its respective fliC and motB 
mutants are quite comparable.
Taken together, these observations suggest that, in presence of toxins TcdA and TcdB, the flagellum of the 
C. difficile R20291 strain plays an important role in amplifying the intestinal inflammatory response during infec-
tion, and that these toxins are necessary for the pro-inflammatory activity of flagella in this CDI animal model.
Flagella and toxins in non-epidemic C. difficile 630Δerm strain are also necessary to induce a 
caecal inflammatory response in the CDI mouse model. To evaluate a potential strain-dependent 
effect for FliC-induced caeca inflammation, we performed the same animal experiments using the non-epidemic 
C. difficile 630Δerm strain and its respective fliC and A−B− mutants. As for R20291 derivatives, comparable fecal 
shedding was observed for all 630Δerm derivative strains (Supplementary Fig. S1C,D) and a cytotoxic activ-
ity was detected in feces of the WT 630Δerm- and the fliC mutant-infected mice, while no cytotoxicity was 
detected in feces of the A−B− mutant-infected animals (Supplementary Fig. S2B). In contrast, in vivo cytotox-
icity was dramatically lower in C. difficile WT 630Δerm-infected mice (600 U), compared to that observed in 
the R20291-infected animals (40 000 U), which is in accordance with the different clinical outcomes observed 
between these animal sets. Indeed, the flagellated WT 630Δerm induced CDI with soft stools, but a moderated 
degree of caecal mucosa inflammation compared to uninfected mice (Fig. 2A,B), and the inflammation level 
was lower (score 8.5, Fig. 2E,F) than that observed in the WT strain R20291-infected mice (score 12). Even if 
an important submucosa edema was observed, the degree of neutrophil infiltrate, epithelial injury and loss of 
goblet cells was considerably reduced in caecal sections of 630Δerm WT-infected mice compared to sections 
of R20291-infected mice. Moreover, as for the fliC mutant in R20291, the 630Δerm fliC and A−B− mutants did 
not induce disease and elicited only a weak degree of caecal mucosa inflammation (Fig. 2C,D) as measured by 
histological scores (Fig. 2E,F). These results suggest that flagella of two different epidemic and non-epidemic C. 
difficile strains contribute with toxins to caecal inflammation during infection in mice, despite major differences 
in the intensity of the inflammation induced by the two strains.
The absence of TLR5 strongly reduces the C. difficile infection-induced caecal inflammation 
of mice. In order to analyze the role of the mucosal TLR5 in the C. difficile flagella-induced inflammatory 
response, we tested the CDI model in C57BL/6 tlr5−/− KO mice, which do not express TLR5 in the intestinal 
mucosa. Mice were infected by oral gavage with the C. difficile R20291 WT strain (n = 10) or its fliC (unflagel-
lated but toxigenic) mutant (n = 10), as well as with the 630Δerm WT strain (n = 10) and the clinical outcome 
and caecal lesions were analyzed. No infected tlr5−/− KO mice developed CDI and all animals survived at day 2 
post-infection regardless of the strain. Neither colitis was observed in infected mice, compared to the group of 
non-infected mice (n = 10), and only mucosal edema was detected in histological sections from caecum of ani-
mals (Fig. 3B–D), probably induced by C. difficile TcdA/TcdB toxins, produced by all tested strains and detected 
in feces of all infected animals (Supplementary Fig. S2C). In accordance with the low level of cytotoxic activity 
detected in WT 630Δerm-infected mice, the lowest inflammation score was observed in animals infected by this 
non-epidemic strain. Altogether, these results strongly suggest that C. difficile flagella-TLR5 interaction leads to a 
pro-inflammatory response of the intestinal mucosa.
The C. difficile flagella, in presence of toxins, induce the NF-κB activation in the caeca of mice. We 
previously showed that the NF-κB and MAPKs signaling were activated by C. difficile flagellin via TLR5 in epithelial 
cells, with a predominant activation of the former20. We thus analyzed the NF-κB activation (IκB-α degradation) in 
the intestine of mice. Significant IκB-α degradation (2 fold) was observed in the R20291 WT-infected mice compared 
to the negative control (Fig. 4A). Nevertheless, non-significant IκB-α degradation was observed in the fliC and A−B− 
mutant-infected animals, compared to R20291 WT-infected mice (Fig. 4A). Interestingly, as for WT-infected mice, a 
www.nature.com/scientificreports/
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strong NF-κB activation was observed in caeca of the motB mutant-infected mice compared to the negative control 
(Fig. 4A). We also analyzed the ERK1/2 and JNK MAPKs activation in the intestine of mice. Significant increase of 
ERK1/2 (1.5 fold) and JNK (2.5 fold) phosphorylation was observed in the R20291 WT- and motB mutant-infected 
mice compared to the negative control (Supplementary Fig. S3A,B). A similar level of ERK1/2 and JNK activation 
was also observed in the caecum of the fliC mutant, but not in the non-toxigenic A−B− mutant-infected animals 
(Supplementary Fig. S3A,B), suggesting a probable action of toxins which are known to also activate MAPKs in 
intestinal cells22. In accordance to the lesser degree of caecal inflammation observed in the 630Δerm WT-infected 
mice, a weak but significant activation of NF-κB, ERK1/2 and JNK, in caecal tissue of these animals (Fig. 4B and 
Figure 2. C. difficile 630Δerm flagella are involved in caecal inflammation of mice. C57BL/6 mice (n = 10) 
were infected by oral gavage or not and caeca were collected at the clinical end point day 2 for histology. 
(A) Representative histology of caecum of healthy uninfected mice (control) with epithelium integrity; (B) 
630Δerm WT-infected mice with moderate desquamation, exudates and necrotic cells in the intestinal lumen, 
edema, and inflammatory submucosa cell infiltration; (C) fliC and (D) A−B− mutant-infected mice with normal 
mucosa (200X magnification). Bar = 200 µm. (E) Inflammation histological scores for individual mice in each 
group. The horizontal lines represent the mean scores for each group of animals. (F) Individual evaluation 
criteria of intestinal inflammation. The bars represent the mean scores for each group of animals and standard 
deviations. *P < 0.01 compared to WT-infected mice.
Figure 3. C. difficile flagella and caecal inflammation in C57BL/6 tlr5−/− KO mice. C57BL/6 tlr5−/− KO mice 
(n = 10) were infected by oral gavage or not and caeca were collected at the clinical end point day 2 for histology. 
(A) Representative histology of caecum of healthy uninfected mice (control) with epithelium integrity; (B) 
R20291 WT-infected mice with mild to moderate edema; (C) R20291 fliC mutant and (D) 630Δerm WT-
infected mice with mild to moderate edema (200X magnification). Bar = 200 µm. (E) Inflammation histological 
scores for individual mice in each group. The horizontal lines represent the mean scores for each group of 
animals. (F) Individual evaluation criteria of intestinal inflammation. The bars represent the mean scores for 
each group of animals and standard deviations. *P < 0.01 compared to R20291 WT-infected mice.
www.nature.com/scientificreports/
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Supplementary Fig. S3C,D). However, no activation of these effectors was observed in caecal tissue from the fliC and 
A−B− mutant-infected mice. Moreover, according to the role of TLR5 pro-inflammatory cell-signaling, no NF-κB 
or MAPK activation was observed in caeca of tlr5−/− KO-infected mice (Fig. 4C and Supplementary Fig. S3E,F). 
These results are consistent with our previous in vitro experiments and suggest that both TcdA/TcdB and flagella are 
required for NF-κB activation in caeca of C. difficile infected mice.
Toxigenic and flagellated C. difficile strains elicit up-regulation of pro-inflammatory cytokine 
genes in the caeca of mice. Finally, we investigated the changes in the transcription of genes encoding 
pro-inflammatory cytokines in the intestinal mucosa of C. difficile-infected mice. We selected a set of genes whose 
over-expression was observed previously (Table 1)20. As expected, at day 2 post-infection the KC gene encoding 
keratinocyte derived chemokine (equivalent of the hIL-8 in the mouse) was highly over expressed (114-fold) 
in the set of R20291 WT-infected mice compared to the control group of non-infected mice (Table 1). A strong 
up-regulation was also observed for the genes encoding the pro-inflammatory cytokines IL-6 and IL-1β (47- 
and 49-fold respectively), in accordance to the clinical and histopathological features observed in this group of 
animals. An up-regulation, but to a lesser extent, was shown for the genes encoding IL-22, TNFα and CXCL-
10 (Table 1). Interestingly, in the fliC mutant-infected mice, expression of KC (hIL-8) was increased by only 
17-fold and the increase of other cytokines (IL-6, IL-1β, IL-22, CXCL-10, and TNFα,) was from 2 to 9-fold, 
compared to the control group, suggesting a role for the flagellum of the strain R20291 in the development of this 
pro-inflammatory profile in the gut of infected animals. In the non-toxigenic A−B− mutant-infected mice, a lower 
KC gene up-regulation was also observed (5-fold relative to the control group) as for the other genes, with the 
exception of the IL -1β encoding gene that showed an over-expression slightly greater than that observed in the 
fliC mutant-infected mice (Table 1). As expected, and according to clinical and histological observations, a strong 
up-regulation (except for TNFα gene) was also observed for all these pro-inflammatory cytokines encoding genes 
in animals infected with the paralyzed flagella motB mutant (Table 1), strongly suggesting that the coexistence of 
flagella and toxins largely contributes to the mucosal injury.
We next tested the role of flagella from the non-epidemic C. difficile 630Δerm strain and its derivative mutants 
in cytokine gene up-regulation using the CDI mouse model. In accordance with clinical and histopathological 
observations, the flagellated WT 630Δerm induced a weak up-regulation of KC, IL-6, IL-1β, IL-22, CXCL-10 
and TNFα genes compared to the WT R20291 (Table 1). This gene up-regulation was further decreased in the 
630Δerm fliC mutant-infected mice and completely null in the 630Δerm A−B− mutant-infected animals, except 
for TNFα. These results indicate that despite differences in virulence between R20291 and 630Δerm C. difficile 
strains, both flagella and toxins contribute to the cytokine gene over-expression from intestinal mucosa in the 
mouse model, strongly suggesting that toxins are necessary for the contributing pro-inflammatory role of C. 
difficile flagella.
We also analyzed the pro-inflammatory cytokines gene transcription in the intestinal mucosa of the C. 
difficile-infected tlr5−/− KO mice. The infection with the R20291 WT strain elicited a 23-fold up-regulation of 
KC expression compared to non-infected KO mice, which was very similar to the level of up-regulation observed 
in R20291 fliC mutant-infected conventional mice (Table 1). These results strengthen the role of flagella-TLR5 
interaction in the intestinal pro-inflammatory response of the CDI animal model. A lesser up-regulation of this 
gene was also observed in the R20291 fliC mutant- and 630∆erm WT-infected tlr5−/− KO mice (Table 1), thus 
suggesting that toxins, and probably other bacterial products, elicit up-regulation of pro-inflammatory cytokines 
genes, independently of flagella in tlr5−/− KO mouse model.
Figure 4. C. difficile flagella-induced degradation of IκB-α. Caecal lysates were prepared as indicated in 
Material and Methods section and proteins were resolved by SDS-PAGE. (A) R20291 derivative-infected 
C57BL/6 mice; (B) 630Δerm derivative-infected C57BL/6 mice, and (C) R20291 derivative- or 630Δerm 
WT-infected C57BL/6 tlr5−/− KO mice. Western blot were then performed using anti-IκB-α, actin antibodies. 
Western blot cropped pictures (full-length blots are in the Supplementary Information file) show the results 
of a representative experiment. The density of the bands was measured using Fusion software. Ratios IκB-α/
actin were calculated and for the negative control (C-, uninfected mice), this ratio was normalized to 1. The 
ratio of the other samples was reported to the negative control. Results represent the mean (n = 10) ± standard 
deviations for each group of animals. *Statistically significant differences (P < 0.05) compared to the negative 
control.
www.nature.com/scientificreports/
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Discussion
Bacterial flagella can be involved in the mucosal inflammatory injury23. Indeed, although the surface components 
of bacteria in the intestinal microbiota play a role in modulating the adaptive immune response, some of these 
components, including flagella, from pathogenic bacteria can reach the mucosa and play a role in amplifying 
the inflammatory response. Flagella from some pathogens such as Salmonella and Pseudomonas aeruginosa, by 
specifically recognizing the innate immune pattern-recognition receptor TLR5, which is expressed at the basolat-
eral pole of the intestinal epithelium, are responsible for inflammatory lesions in the mucosal epithelium during 
infection18, 24. The bacterial flagellins-TLR5 interaction elicits the MAPKs and NF-κB TLR5-related signaling 
pathways, thus inducing a pro-inflammatory response from host16.
The role of C. difficile flagella in the gut inflammatory response remains to be demonstrated. The predicted 
TLR5-agonist of C. difficile flagellin, which shares the conserved amino acids recognized by TLR5 with other 
mucosal pathogens, but not with flagellins known to evade TLR525, 26, was previously confirmed by studies from 
Yoshino et al. and ourselves19, 20. We observed a predominant role for NF-κB, accounting for the importance of 
this major transcription factor in the C. difficile flagellin-associated pathogenesis27.
C. difficile toxins have been considered as the only pathogenic factors involved in intestinal lesions observed 
during CDI, and several studies have shown their role in stimulating pro-inflammatory signaling pathways28. 
The first evidence of the contribution of C. difficile TcdB to the flagellin-induced inflammatory activity was 
reported by Yoshino et al.19. They hypothesize that toxin B by affecting tight junctions facilitate the access of 
flagellin to its receptor in polarized cell monolayers. In a recent report, Kasendra et al.29 suggest that C. difficile 
toxins facilitate bacterial colonization by disrupting cell polarity allowing pathogen-associated molecular pat-
terns (PAMPs) to access the exposed basolateral epithelial surface and trigger the production of inflammatory 
cytokines. Nevertheless, the synergy between toxins and other bacterial compounds involved in inflammation has 
never been demonstrated in vivo. For the first time, we show the putative role of flagella in C. difficile pathogenesis 
in a CDI mouse model21. In this model, we reproduced pathogenesis observed in human CDI as well as different 
clinical outcomes depending on two distinct clinical strains and demonstrated that the absence of flagella in toxin 
producing bacteria dramatically decreases the degree of mucosal inflammation in mice.
We previously reported no difference in the in vitro toxin gene expression between the fliC-R20291 mutant 
and its respective wild-type strain, but increased toxicity in the fliC-630∆erm flagella mutant compared to its 
respective WT strain30. In agreement with these results, our previous in vivo transcriptomic analysis performed 
in the gnotobiotic mouse model, revealed no or weak differences in the toxin gene expression between this 
fliC-R20291 mutant and its parental wild-type strain31. Therefore, toxin gene regulation in absence of FliC is quite 
different between strains 630 and R20291 and the high mortality previously observed in the monoxenic mice 
infected by the fliC-R20291 mutant might be explained not by an increase in toxin gene expression but by the reg-
ulation of other genes whose expression is dependent on flagella31. In the present work, we used a different mouse 
model, the conventional mouse model21, much closer to the human CDI, in which both R20291 and 630∆erm 
strains and their respective fliC mutants induced similar cytotoxicity titer levels in feces.
In this study, the presence of toxins without the flagella was not enough to elicit the high degree of epithelial 
lesions observed in WT R20291-infected mice. The absence of flagella or motility could prevent the fliC R20291 
mutant to reach the mucosa and thus to produce inflammatory lesions induced by toxins alone. However, in 
our study, we found levels of fecal colonization and cytotoxic activity in feces in the unflagellated (fliC) and 
non-motile (motB) mutant-infected mice, which were similar to those observed in the WT R20291-infected 
mice, thus reflecting successful intestinal colonization by these flagellar mutants in this CDI model. Moreover, 
the flagella-paralyzed motB mutant was not only able to colonize the mucosa, but also to produce toxins and 
elicit mucosal lesions as the WT strain. Therefore, in the context of the natural CDI, even if other bacterial fac-
tors, bacterial fitness or metabolic adaptation capability could play a role in the pathogenesis, flagella highly 
contribute to the development of a detrimental inflammatory host response and the outcome of CDI as long as 
Set of infected mice
Genes*
KC IL-6 IL-1β IL-22 CXCL-10 TNFα
Conventional mice
 R20291 WT strain 113, 5 46, 8 49, 3 5, 7 9, 7 8, 2
 R20291 fliC− mutant 17, 5 9, 3 7, 9 3, 7 2, 2 2, 9
 R20291 A−B− mutant 5, 1 4, 9 10, 0 2, 8 1, 8 1, 6
 R20291 motB− mutant 92, 5 39, 0 32, 4 41, 5 18, 0 5, 4
 630∆erm WT strain 14, 9 8, 3 12, 9 4, 4 3, 5 4, 6
 630∆erm fliC− mutant 8, 6 7, 4 7, 9 1, 7 3, 9 3, 9
 630∆erm A−B− mutant 1, 5 1, 7 1, 7 1, 5 1, 7 2, 8
tlr5−/− KO mice
 R20291 WT strain 23, 0 3, 2 11, 1 15, 4 2, 6 6, 0
 R20291 fliC− mutant 14, 9 1, 5 1, 0 6, 8 1, 4 1, 0
 630∆erm WT strain 8, 4 2, 1 8, 7 8, 5 2, 2 3, 0
Table 1. Fold expression of pro-inflammatory cytokine encoding genes of C. difficile-infected mice. *The mean 
Ct from each group is reported to those of the negative control and with the expression of the GAPDH gene for 
each set.
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toxins exert their action on the epithelium. Interestingly, this is not the case of cholera, which is the archetypal 
non-inflammatory diarrheal disease. In V. cholerae infection no synergy should occur between flagella and chol-
era toxin, which induces non-inflammatory watery diarrhea. In the case of CDI, it seems more evident that tox-
ins, by eliciting their actions on the cell cytoskeleton and epithelial tight junctions, could promote the interaction 
between the FliC monomers and the newly exposed TLR5 and the subsequent pro-inflammatory epithelial host 
response. According to this role of C. difficile flagella, analysis of the CDI elicited by R20291 and 630Δerm C. 
difficile strains in the tlr5−/− KO mice, which do not express TLR5 in the intestinal mucosa, strengthens the role 
of the TLR5-related flagellar signaling in the pathogenesis of C. difficile. Indeed, mice infected by the epidemic 
R20291 or the non-epidemic 630Δerm strains developed only mucosal edema with a very low inflammation 
score, without clinical signs of CDI. This mucosal edema was probably induced by TcdA/TcdB toxins, which were 
produced by all the tested strains.
We previously compared the role of R20291 and 630Δerm C. difficile strains in adhesion and colonization 
in vitro and in vivo and showed major behavioral differences between these strains in a germ-free (gnotoxenic) 
mouse model30. In the current study, we show another important role for C. difficile flagella in eliciting an inflam-
matory host response shared by both strains, but according to the hypervirulent traits of strain R20291, differ-
ences persist in the degree of elicited response which may be linked to the level of in vivo regulation of toxin 
synthesis. Nevertheless, in the two strains, toxins alone were not enough to induce the clinical manifestations and 
the mucosal lesions observed in this CDI mouse model. Considering the high homology in TLR5-recognizing 
motifs in FliC from the two strains, we can suggest a similar role for flagella from the two strains in eliciting a 
pro-inflammatory immune response during CDI.
Our work contributes to the knowledge about the virulence factors and pathogenesis of C. difficile and high-
lights other bacterial and host targets in the control of CDI. C. difficile flagellin might constitute an interesting 
vaccine candidate leading to a protective immune response against intestinal pathogens. Interestingly, purified 
Salmonella Typhimurium-derived flagellin protects mice from CDI32. In this context, by stimulating TLR5, flagel-
lin could contribute to the bacterial clearance. On the other hand, the outcome of the CDI could be modulated by 
targeting the pro-inflammatory signaling pathways so as to reduce the severity of the lesions induced by a strong 
inflammatory response. Thereby, by deciphering the regulation mechanisms of the TLR5 signaling cascade, it 
would be possible to target potential effectors of the pro-inflammatory response in order to reduce the effects of 
a deleterious response.
Altogether, our results strongly suggest the role of the C. difficile flagella-TLR5 interaction leading to a 
pro-inflammatory response of the intestinal mucosa in synergy with TcdA and TcdB. Therefore, the C. difficile 
flagellin would exert its action on the pivotal NF-κB signaling pathway through exposed TLR5, thus resulting in 
the development of a deleterious innate immune response which contributes to the pathogenesis of this intestinal 
pathogen.
Materials and Methods
Bacterial strains and growth conditions. The C. difficile strains used in this study were NAP1/027 
R20291 wild-type strain (WT), the fliC and the motB flagellar mutants30, and the tcdA and tcdB double mutant 
(A−B−)33, and the respective fliC-complemented strain (containing pMTL-SB1 fliC-complementation plasmid) 
as described previously. These mutants were created from C. difficile R20291 by insertional inactivation using 
the ClosTron gene knock-out system. For some experiments C. difficile 630Δerm strain and its fliC30 and A−B− 6 
isogenic mutants (ClosTron) were also used. C. difficile strains were cultured in Brain Heart Infusion (BHI) agar 
or broth (Oxoid) in an anaerobic chamber (atmosphere of 90% N2, 5% CO2 and 5% H2) at 37 °C. Strains contain-
ing the pMTL plasmid were grown in BHI supplemented with 15 µg/ml thiamphenicol. Escherichia coli Top10 and 
BL21 were cultured in Luria-Bertani agar or broth (Oxoid) supplemented with 50 µg/ml kanamycin.
C. difficile spores for mouse challenge. C. difficile spores were prepared at 37 °C in an anaerobic chamber 
as previously described by Burns et al.34. Briefly, a preculture was grown overnight in BHI supplemented with 
yeast extract (5 mg/ml, BD) and L-cysteine (0.1%, Merck) (BHIS) and was used to inoculate a starter preculture 
in BHIS, which was grown to OD600nm 0.2–0.5. Sporulation was then induced in BHIS by inoculation with the 
starter culture (1 in 100) and incubation for 7 days. Cultures were then washed in sterile water and heated at 70 °C 
for 25 min to kill vegetative cells and collect spores. Enumeration of spores was performed on BHI agar supple-
mented with the bile salt taurocholate 0.1% (Sigma-Aldrich).
Animal model. 6–7 week old female C57BL/6 mice were purchased from Charles River (France). 6–7 week 
old female C57BL/6 tlr5−/− knock-out (KO) mice were kindly provided by Thierry Pedron (Philippe Sansonetti 
laboratory, Pasteur Institute, Paris) and were housed and bred at the animal facility of the Faculty of Pharmacy, 
Paris-Sud University. Mice were housed in groups of 5 in sterile cages containing irradiated food and autoclaved 
water. To overcome their resistance to CDI, all mice received an antibiotic pretreatment, as previously described21. 
Mice consumed an antibiotic mixture of kanamycin (0.4 mg/ml), gentamicin (0.035 mg/ml), colistin (850 U/
ml), metronidazole (0.215 mg/ml) and vancomycin (0.045 mg/ml) in the drinking water for 3 days. After this 
treatment, mice were switched to regular autoclaved water. Two days later, all mice received a single dose of clin-
damycin (250 µg) by intraperitoneal injection (IP), 24 h prior to challenge. Mice were then infected by oral gavage 
with 105 spores of C. difficile strains. Mice from the control group were pretreated with antibiotic but were orally 
gavaged with water. Animals were observed daily for signs of disease (diarrhea, hunched posture and ruffled fur). 
Two days after challenge, mice were euthanized and caecal tissues were collected, washed with PBS and cut in 3 
pieces for further analyses (gene expression, histopathology and immunoblotting).
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Animal statements. For the mouse studies, animal care and animal experiments were carried out in strict 
accordance with the Committee for Research and ethical Issues of the International Association for the study 
of pain (IASP). The animal experimentation protocol was approved by the Animal Welfare Committee of the 
Paris-Sud University and animal experiments were performed according to the University Paris-Sud guidelines 
for the husbandry of laboratory animals.
Fecal shedding of C. difficile during infection of mice. Unit forming colonies (UFC)/g feces of vege-
tative cells were obtained after serial dilution of feces in PBS and plating in BHI medium supplemented with 3% 
horse blood and Oxoid C. difficile supplement (250 mg/L D-cycloserine, 8 mg/L Cefoxitin). Plates were incubated 
in an anaerobic chamber (atmosphere of 90% N2, 5% CO2 and 5% H2) at 37 °C. For spore count, an alcoholic 
shock was performed and then samples were plated in the same medium supplemented with taurocholate 0.1%.
Quantitative histologic assessment of inflammation in the caecum. The caecal segments assigned 
for histological studies were fixed in 10% neutral formalin for 18 h, transferred into 70% ethanol and paraffin 
embedded. 3 µm sections were stained with hematoxylin and eosin and analyzed in a blinded manner using a his-
topathological scoring scheme. Briefly, caecal inflammation was evaluated with the following criteria measured 
on 10 different microscopic fields: submucosal edema, degree of lamina propria mononuclear cell infiltration, 
epithelial damage as previously described35. We added the criteria of loss of goblet cells which was graded as fol-
lows: 0: >28; 1: 11–28; 2: 1–10; 3: <1 36 (Supplementary Table S1).
SDS-PAGE and Western blot analysis. Caecal tissue was disrupted and homogenized in a buffer con-
taining 186 mM β-mercaptoethanol, 1% bromophenol blue, 10 mM NaF, 25 mM NaPPi, 1 mM Na3VO4, using 
a microtube adapted pellet mixer. After lysis, samples were incubated at 100 °C for 10 min and centrifuged to 
remove insoluble materials. Proteins were resolved by SDS–PAGE, and gels were transferred to polyvinylidene 
difluoride (PVDF) membrane (GE Healthcare). For immunoblotting, membranes were washed with TBS 0.1% 
Tween 20, blocked in TBS (0.1% Tween 20, 5% milk) and probed overnight with the following specific anti-
bodies: anti-ERK1/2, anti-JNK, anti-IκBα, anti-phosphorylated (anti-p)ERK1/2 and anti-pJNK (Cell Signaling 
Technology), or anti-actin (Millipore). Blots were then incubated with HRP-linked secondary antibodies (Cell 
Signaling Technology), followed by chemiluminescence detection with the ECL Plus kit (Millipore) according to 
the manufacturer’s instructions. Chemiluminescence signals were detected with a Fusion FX (Vilber Lourmat) 
and analyzed densitometrically with Fusion-CAPT software (Vilber Lourmat).
Quantitative real-time reverse transcription PCR (qRT-PCR). Tissue from the caecum was sub-
merged in RNAlater RNA Stabilization Reagent (Qiagen) to protect the RNA. After stabilization for 15 min at 
room temperature, tissue was lysed using Lysing Matrix D and a FastPrep apparatus (MP Biomedicals). Total 
RNA was then isolated using the RNeasy Mini Kit (Qiagen). RNA quantification and quality were assessed by 
a 2100 Bioanalyzer Agilent. RNA was reverse-transcribed to first strand cDNA using the RT² First Strand Kit 
(Qiagen). cDNA was prepared from 1 µg RNA using SuperScript™ III Reverse Transcriptase (Invitrogen) with 
random primers as described by the manufacturer. qPCR was performed in a 10 µl reaction volume containing 
4 ng of cDNA, 5 µl of SSo Advanced™ SYBR Green Supermix (Bio-Rad) and 500 nM gene-specific primers. The 
primers designed with Primer3 software, not to amplify genomic DNA, are listed in Supplementary Table S2. 
Reactions were run on a CFX96 Real-time system (Bio-Rad) with the following cycling conditions: 30 s polymer-
ase activation at 95 °C and 40 cycles at 95 °C for 5 s and 60 °C for 10 s. An additional step from a start at 65 °C to 
95 °C (0.5 °C/0.5 s) was performed to establish a melting curve in order to verify the specificity of the real-time 
PCR reaction for each primer pair. The results were normalized using the geometric averaging of the GAPDH as 
reference gene. Normalized relative quantities were calculated using the ΔΔCT method37, 38.
Data were collected from three independent experiments and expressed as down- or up-regulation fold. 
The statistical differences were determined by Student’s t-test. P values < 0.05 were considered statistically 
significant.
Toxicity assay on Vero cell line. Vero kidney epithelial cell line (kindly donated by I. Beau, INSERM 
UMR-S 984, France) were grown in DMEM with L-glutamine (Invitrogen) supplemented with 10% 
heat-inactivated fetal calf serum at 37 °C in an atmosphere containing 5% CO2. Cell lines were harvested from the 
flask with trypsin (0.5 mg/ml)/EDTA (0.2 mg/ml), washed once with medium and seeded into culture plates (TPP, 
ATGC Biotechnologies) at the desired cell densities and incubated at 37 °C in an atmosphere containing 5% CO2 
before experiments. Quantitative detection of toxin in fecal samples was performed by cytotoxicity assay. Briefly, 
feces from each mouse were collected and diluted in PBS at 1 mg/ml. After thorough mixing, the samples were 
centrifuged at 12000 g for 5 min, and the supernatants were collected and then sterilized through a 0.22 µm filter. 
Confluent Vero cells in 96-well plates were exposed to 1:2 to 1:262144 (vol/vol) dilutions of the supernatants in 
Dulbecco’s Modified Eagle Medium (DMEM) (Gibco) containing 10% heat-inactivated Fetal Bovine Serum (FBS) 
(Gibco). The plates were incubated at 37 °C in 5% CO2 and morphological changes were observed by microscopy 
after 24 h. The endpoint titers were expressed as the reciprocal of the highest dilution giving a 50% cytopathic 
effect (CPE). The assays were performed in triplicate on independent culture supernatants.
Statistical analysis. Results from histologic assessment, fecal shedding, Western blot analysis, and toxicity 
assay are expressed as means ± sem. Different groups were compared by using Mann and Whitney test performed 
using StatEL software. P values < 0.05 were considered statistically significant.
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